FR2133505B1 - - Google Patents

Info

Publication number
FR2133505B1
FR2133505B1 FR7113326A FR7113326A FR2133505B1 FR 2133505 B1 FR2133505 B1 FR 2133505B1 FR 7113326 A FR7113326 A FR 7113326A FR 7113326 A FR7113326 A FR 7113326A FR 2133505 B1 FR2133505 B1 FR 2133505B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7113326A
Other versions
FR2133505A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jouveinal SA
Original Assignee
Jouveinal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jouveinal SA filed Critical Jouveinal SA
Priority to FR7113326A priority Critical patent/FR2133505B1/fr
Priority to DE19712124937 priority patent/DE2124937C/de
Priority to US05/146,298 priority patent/US3934016A/en
Priority to GB166072A priority patent/GB1337093A/en
Priority to CA137,727A priority patent/CA988423A/en
Priority to NL7204947A priority patent/NL7204947A/xx
Publication of FR2133505A1 publication Critical patent/FR2133505A1/fr
Application granted granted Critical
Publication of FR2133505B1 publication Critical patent/FR2133505B1/fr
Priority to US05/544,039 priority patent/US3985892A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7113326A 1971-04-15 1971-04-15 Expired FR2133505B1 (fr)

Priority Applications (7)

Application Number Priority Date Filing Date Title
FR7113326A FR2133505B1 (fr) 1971-04-15 1971-04-15
DE19712124937 DE2124937C (de) 1971-04-15 1971-05-19 Medikament zur percutanen Behandlung von lokalen Ödemen
US05/146,298 US3934016A (en) 1971-04-15 1971-05-24 Pharmaceutical preparation for percutaneous treatment of local edemas
GB166072A GB1337093A (en) 1971-04-15 1972-01-13 Pharmaceutical preparation for the treatment of local oedemas
CA137,727A CA988423A (en) 1971-04-15 1972-03-21 Pharmaceutical preparation for percutaneous treatment of local edemas
NL7204947A NL7204947A (fr) 1971-04-15 1972-04-13
US05/544,039 US3985892A (en) 1971-04-15 1975-01-27 Pharmaceutical preparation for percutaneous treatment of local edemas employing acetazolamide

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7113326A FR2133505B1 (fr) 1971-04-15 1971-04-15

Publications (2)

Publication Number Publication Date
FR2133505A1 FR2133505A1 (fr) 1972-12-01
FR2133505B1 true FR2133505B1 (fr) 1974-08-23

Family

ID=9075322

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7113326A Expired FR2133505B1 (fr) 1971-04-15 1971-04-15

Country Status (5)

Country Link
US (1) US3934016A (fr)
CA (1) CA988423A (fr)
FR (1) FR2133505B1 (fr)
GB (1) GB1337093A (fr)
NL (1) NL7204947A (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2542998B1 (fr) * 1983-03-24 1986-01-31 Rhone Poulenc Sante Nouvelle forme transdermale du dinitrate d'isosorbide
US20080045611A1 (en) * 2006-08-17 2008-02-21 Milan Radojicic Methods for the therapeutic use of a carbonic anhydrase inhibitor for reducing spinal cord edema

Also Published As

Publication number Publication date
FR2133505A1 (fr) 1972-12-01
GB1337093A (en) 1973-11-14
CA988423A (en) 1976-05-04
US3934016A (en) 1976-01-20
NL7204947A (fr) 1972-10-17
DE2124937A1 (fr) 1972-07-06

Similar Documents

Publication Publication Date Title
AR196074A1 (fr)
AU2658571A (fr)
FR2133505B1 (fr)
AU2691671A (fr)
AU2564071A (fr)
AU2684071A (fr)
AU2742671A (fr)
AU2485671A (fr)
AU2894671A (fr)
AU2941471A (fr)
AU2952271A (fr)
AU3005371A (fr)
AU2706571A (fr)
AU2740271A (fr)
AU2726271A (fr)
AU2963771A (fr)
AU2486471A (fr)
AU2503871A (fr)
AU2940971A (fr)
AU2938071A (fr)
AU2930871A (fr)
AU2927871A (fr)
AU2907471A (fr)
AU2577671A (fr)
AU2885171A (fr)